Literature DB >> 7608707

Multifocal motor neuropathy with conduction block: a study of 24 patients.

P Bouche1, A Moulonguet, A B Younes-Chennoufi, D Adams, N Baumann, V Meininger, J M Léger, G Said.   

Abstract

Twenty four patients with pure motor neuropathy are reported. The chronic motor involvement associated with fasciculations and cramps, mainly in the arms, led, in most patients, to an initial diagnosis of motor neuron disease. In some patients (nine of 24), there was no appreciable muscle atrophy. Tendon reflexes were often absent or weak. The finding of persistent multifocal conduction block confined to motor nerve fibres raises questions about the nature and the importance of this syndrome. Segmental reduction of motor conduction velocity occurred at the site of the block, but significant slowing of motor nerve conduction was not found outside this site. The response to intravenous IVIg treatment seems to be correlated with the absence of amyotrophy. Patients with little or no amyotrophy had an initial and sustained response to IVIg, and did not develop amyotrophy during the follow up study. They could be considered to have a variant of chronic inflammatory demyelinating polyneuropathy. Patients with pronounced amyotrophy independent of the disease duration did not respond as well to IVIg treatment, suggesting the existence of a distinct entity. Among the patients treated about two thirds who had an initial good response to IVIg had high or significant antiganglioside GM1 (anti-GM1) antibody titres, but there was no correlation between the high titres before treatment and long lasting response to IVIg treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608707      PMCID: PMC1073599          DOI: 10.1136/jnnp.59.1.38

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  41 in total

1.  Anti-GM1 IgM antibodies in motor neuron disease and neuropathy.

Authors:  E Nobile-Orazio; M Carpo; G Legname; N Meucci; S Sonnino; G Scarlato
Journal:  Neurology       Date:  1990-11       Impact factor: 9.910

2.  A computer simulation of conduction block: effects produced by actual block versus interphase cancellation.

Authors:  E K Rhee; J D England; A J Sumner
Journal:  Ann Neurol       Date:  1990-08       Impact factor: 10.422

3.  Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera.

Authors:  D Adams; T Kuntzer; D Burger; M Chofflon; M R Magistris; F Regli; A J Steck
Journal:  J Neuroimmunol       Date:  1991-06       Impact factor: 3.478

Review 4.  Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies.

Authors:  A Pestronk
Journal:  Muscle Nerve       Date:  1991-10       Impact factor: 3.217

Review 5.  Motor neuron syndromes and monoclonal IgM antibodies to gangliosides.

Authors:  A J Steck; D Adams
Journal:  Adv Neurol       Date:  1991

Review 6.  Separating motor neuron diseases from pure motor neuropathies. Multifocal motor neuropathy with persistent conduction block.

Authors:  A J Sumner
Journal:  Adv Neurol       Date:  1991

7.  IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block.

Authors:  M Santoro; F P Thomas; M E Fink; D J Lange; A Uncini; N H Wadia; N Latov; A P Hays
Journal:  Ann Neurol       Date:  1990-09       Impact factor: 10.422

8.  Neuropathy with onion bulb formations and pure motor manifestations.

Authors:  R N Auer; R B Bell; M A Lee
Journal:  Can J Neurol Sci       Date:  1989-05       Impact factor: 2.104

9.  Motor neuropathy with multifocal conduction blocks.

Authors:  P Van den Bergh; E L Logigian; J J Kelly
Journal:  Muscle Nerve       Date:  1989-01       Impact factor: 3.217

10.  The spectrum of neurologic disease associated with anti-GM1 antibodies.

Authors:  S A Sadiq; F P Thomas; K Kilidireas; S Protopsaltis; A P Hays; K W Lee; S N Romas; N Kumar; L van den Berg; M Santoro
Journal:  Neurology       Date:  1990-07       Impact factor: 9.910

View more
  26 in total

Review 1.  Specificity of antiglycolipid antibodies.

Authors:  N Baumann
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  G Comi; L Roveri
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 3.  Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.

Authors:  Lotte Vlam; W-Ludo van der Pol; Elisabeth A Cats; Dirk C Straver; Sanneke Piepers; Hessel Franssen; Leonard H van den Berg
Journal:  Nat Rev Neurol       Date:  2011-11-22       Impact factor: 42.937

4.  The effect of treatment upon temporal dispersion in IvIg responsive multifocal motor neuropathy.

Authors:  A Ghosh; A Virgincar; R Kennett; M Busby; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

5.  A practical definition of conduction block in IvIg responsive multifocal motor neuropathy.

Authors:  A Ghosh; M Busby; R Kennett; K Mills; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

Review 6.  Multifocal motor neuropathy.

Authors:  E Nobile-Orazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

7.  Single fibre electromyography in multifocal motor neuropathy with persistent conduction blocks.

Authors:  A Lagueny; G Le Masson; P Burbeaud; P Deliac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

Review 8.  Subcutaneous immunoglobulin: opportunities and outlook.

Authors:  S Misbah; M H Sturzenegger; M Borte; R S Shapiro; R L Wasserman; M Berger; H D Ochs
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

Review 9.  Multifocal motor neuropathy: current therapies and novel strategies.

Authors:  Eduardo Nobile-Orazio; Francesca Gallia
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

10.  Multifocal motor neuropathy: clinical and electrophysiological findings.

Authors:  A Jaspert; D Claus; H Grehl; B Neundörfer
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.